Keywords: GlaxoSmithKline, Quest Diagnostics, Share buyback, Sells shares

GlaxoSmithKline gets shot of Quest Diagnostics shares for around $1.7 billion

Article | 03 February 2011

Print This

UK pharma giant GlaxoSmithKline (LSE: GSK) this week said that it has sold its entire holding of 30,755,151 shares of common ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in